Results 1 to 10 of about 1,026,832 (278)

Molecular modelling of the HCMV IL-10 protein isoforms and analysis of their interaction with the human IL-10 receptor. [PDF]

open access: yesPLoS ONE, 2022
The human cytomegalovirus (HCMV) UL111A gene encodes several homologs of the cellular interleukin 10 (cIL-10). Alternative splicing in the UL111A region produces two relatively well-characterized transcripts designated cmvIL-10 (isoform A) and LAcmvIL-10
Simone Queiroz Pantaleão   +10 more
doaj   +8 more sources

Correction: Molecular modelling of the HCMV IL-10 protein isoforms and analysis of their interaction with the human IL-10 receptor. [PDF]

open access: yesPLoS ONE, 2023
[This corrects the article DOI: 10.1371/journal.pone.0277953.].
Simone Queiroz Pantaleão   +10 more
doaj   +6 more sources

Elevated IgA and IL-10 levels in very-early-onset inflammatory bowel disease secondary to IL-10 receptor deficiency [PDF]

open access: yesRevista Paulista de Pediatria, 2021
Objective: To report two patients with very-early-onset inflammatory bowel disease (VEOIBD) secondary to interleukin-10 receptor (IL-10R) mutations, explore immunophenotyping data and plasma cytokine profile on these cases compared to healthy controls ...
Natascha Silva Sandy   +8 more
doaj   +5 more sources

The Association of Polymorphisms in Interleukin-6 (IL-6), Interleukin-10 (IL-10), IL-6 Receptor, and IL-10 Receptor Genes with the Risk of Pediatric Inflammatory Bowel Disease [PDF]

open access: yesJournal of Inflammation Research
Paulina Krawiec,1 Monika Lejman,2 Elżbieta Pac-Kożuchowska1 1Department of Pediatrics and Gastroenterology, Medical University of Lublin, Lublin, 20-059, Poland; 2Independent Laboratory of Genetic Diagnostics, Medical University of ...
Krawiec P, Lejman M, Pac-Kożuchowska E
doaj   +4 more sources

IL‐10 Receptor Neutralization–Induced Colitis in Mice: A Comprehensive Guide [PDF]

open access: yesCurrent Protocols, 2021
AbstractInterleukin‐10 (IL‐10) and its receptor (IL‐10R) have been foremost targets to understand inflammatory bowel disease (IBD) pathogenesis. For the past several decades, IL‐10‐deficient (Il10‐/‐) mice were considered one of the best models to study immune‐mediated colitis.
Piu, Saha   +4 more
openaire   +3 more sources

IL-10 and IL-10 Receptor Mutations in Very Early Onset Inflammatory Bowel Disease [PDF]

open access: yesGastroenterology Research, 2017
Very early onset inflammatory bowel disease (VEO-IBD) is a unique disease entity with a complex genetic susceptibility in affected patients. Next-generation gene sequencing techniques have revealed various monogenetic mutations contributing to the pathogenesis of VEO-IBD, including interleukin 10 (IL-10) and IL-10 receptor (IL-10R) mutations.
Zhu, Lei   +5 more
openaire   +4 more sources

Blocking IL-10 signaling with soluble IL-10 receptor restores in vitro specific lymphoproliferative response in dogs with leishmaniasis caused by Leishmania infantum. [PDF]

open access: yesPLoS ONE, 2021
rIL-10 plays a major role in restricting exaggerated inflammatory and immune responses, thus preventing tissue damage. However, the restriction of inflammatory and immune responses by IL-10 can also favor the development and/or persistence of chronic ...
Catiule de Oliveira Santos   +8 more
doaj   +2 more sources

Hepatocarcinogenesis in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Emerging Roles of Interleukin-10 and Transcriptomic Insights into IL-10 Signaling Rewiring [PDF]

open access: yesBiomedicines
Metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive inflammatory form, metabolic dysfunction-associated steatohepatitis (MASH), are increasingly recognized as key drivers of hepatocellular carcinoma (HCC).
Helena Solleiro-Villavicencio   +4 more
doaj   +2 more sources

IL-10 Receptor Signaling Is Essential for TR1 Cell Function In Vivo [PDF]

open access: yesThe Journal of Immunology, 2017
Abstract IL-10 is essential to maintain intestinal homeostasis. CD4+ T regulatory type 1 (TR1) cells produce large amounts of this cytokine and are therefore currently being examined in clinical trials as T cell therapy in patients with inflammatory bowel disease.
Leonie Brockmann   +15 more
openaire   +3 more sources

Rational Structure-Based Rescaffolding Approach to De Novo Design of Interleukin 10 (IL-10) Receptor-1 Mimetics. [PDF]

open access: yesPLoS ONE, 2016
Tackling protein interfaces with small molecules capable of modulating protein-protein interactions remains a challenge in structure-based ligand design.
Gloria Ruiz-Gómez   +7 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy